|
HS Code |
277495 |
As an accredited 5-Bromo-2-Chloro-3-Cyanopyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 5-Bromo-2-Chloro-3-Cyanopyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Chemistry evolves by meeting the rising demand for specialized molecules, and 5-Bromo-2-Chloro-3-Cyanopyridine keeps showing up in critical conversations among chemists and pharmaceutical developers alike. With its unique substitution pattern on the pyridine ring, this compound unlocks a toolkit of transformations for laboratories and businesses that need sophisticated intermediates. The model—5-Bromo-2-Chloro-3-Cyanopyridine—brings together bromine, chlorine, and cyano groups on the same aromatic ring, which gives the molecule reactive corners for downstream chemistry. Anyone who’s spent time on late-night synthetic runs knows the value of a well-positioned halogen on a pyridine for further cross-coupling or nucleophilic reactions.
Boasting a chemical formula of C6H2BrClN2, 5-Bromo-2-Chloro-3-Cyanopyridine packs three functional handles onto a six-membered aromatic framework. The bromine atom at the five-position sits ready for Suzuki or Sonogashira couplings, making custom functionalization feasible with relatively standard palladium catalysis. A cyano group at the three position directs metalation or serves as a precursor for other transformations. Chlorine at the two position makes nucleophilic aromatic substitution (SNAr) reactions workable, unlocking downstream diversification with alcohols, amines, or thiols. Purity often breaks above 97%, and for most labs, reliable access to material with solid stability and defined melting point streamlines method development.
Within the field of medicinal chemistry, researchers face constant pressure to expand chemical diversity and flag new leads for biological targets. Over the years, pyridine scaffolds have shown their worth in everything from kinase inhibitors to agrochemicals. What sets this particular intermediate apart is how it positions three moieties for stepwise modification—a single molecule, yet enough starting points to build out analog series. In the daily grind of drug discovery, that flexibility means fewer steps and quicker synthesis of diverse compounds, whether teams are after SAR (structure-activity relationship) work or more sweeping chemical library construction.
Having handled a fair share of pyridines myself, the rate at which these tri-substituted variants insert themselves into synthetic schemes reflects a practical mindset: reduce the total number of steps, increase yield, and leave mistakes behind in the process. Anyone with a hand in process chemistry will appreciate that 5-Bromo-2-Chloro-3-Cyanopyridine stands up to bench handling without the air sensitivity and instability seen in some other heterocyclic intermediates. No one wants to return from lunch to a decomposed batch, and this molecule’s shelf longevity proves its worth during scale-up.
5-Bromo-2-Chloro-3-Cyanopyridine finds itself in the thick of creative synthesis. Academic labs report using it in stepwise functionalization of the pyridine nucleus, with bromine as a launch pad for Suzuki-Miyaura cross-couplings while the chlorine enables a subsequent aromatic substitution. In some cases, researchers exploit orthogonal reactivity by first leveraging the cyano group for directed ortho-lithiation before introducing more complex appendages. If your goal is to populate a chemical library with a range of polar and non-polar groups, this compound makes strategy possible in fewer steps.
Scrolling through recent literature, this intermediate also pops up in patent filings for kinase blockers and crop protectants. Development teams lean on it as a reliable central node to explore new drug-like space, especially since pyridine derivatives often meet the structural rules favored in pharmaceutical R&D. For chemists designing molecules to dodge metabolic liabilities, a cyano group at the three position can help tune logP and block hot spots for aromatic hydroxylation.
It’s tempting to treat all pyridine derivatives as interchangeable, but the substitution choices deeply affect practical utility. Take 2,3-dichloropyridine, for instance, which lacks the cyano group. Such molecules, while reactive, don’t give the same breadth of further functionalization options. Add a cyano group, and new conjugations and ring-fusions open up. Compared to molecules carrying only a single halogen or a carboxylic acid instead of a cyano group, 5-Bromo-2-Chloro-3-Cyanopyridine supports more modular assembly. This combination accommodates different catalytic protocols, from nickel-catalyzed aminations to robust copper-catalyzed modifications.
My own experience in lead optimization pushed me to choose intermediates based on how many steps and purifications a compound can spare me. Fewer changes to the core scaffold can translate to savings in both time and raw material costs—a major deal for pilot-scale production. Whenever cost pressure meets the requirement for structural novelty, flexibility wins. The tri-functional nature of this pyridine lets teams run parallel routes and quickly progress the most promising hits.
Chemists appreciate reliability when it comes to reagents, particularly those sensitive to moisture or oxidation. In my hands, 5-Bromo-2-Chloro-3-Cyanopyridine holds up well under typical lab storage. While some halogenated pyridines can drift or yellow over months, this compound often remains stable in sealed packaging, even at ambient temperature. Consistency like that reduces rejections during analytical QC and saves projects from avoidable headaches.
As with many aromatic nitriles, a reasonable caution around inhalation and skin contact serves everyone well. I’ve leaned on standard practice: a properly vented hood, gloves, and goggles. This intermediate doesn’t introduce wild hazards beyond those expected from pyridine derivatives, and waste disposal follows the usual routes for halogenated organics. A practical bonus: the limited odor compared to unsubstituted pyridines means less disruptive working conditions.
Some procurement managers voice concerns about sourcing specialty chemicals reliably, especially ones carrying more than one halogen atom. Though production routes to 5-Bromo-2-Chloro-3-Cyanopyridine have matured in recent years, supply chain shocks can catch buyers off guard. Certain regulatory changes—for instance, shipping restrictions on halogenated substances—sometimes squeeze availability in key markets. Success stories in scale-up hinge on finding suppliers who communicate analytical data up front and don’t skimp on impurity profiling. Any process chemist will tell you that discovering an unexpected side-product mid-campaign chews up both budget and morale.
Another barrier: unfamiliarity among R&D teams. A compound like this—easy to miss in a catalog crowded with thousands of pyridine variations—sometimes requires old-fashioned word-of-mouth or a literature alert before landing in a new synthetic scheme. Institutions that invest in internal knowledge-sharing and project tracking make it easier for individual researchers to discover promising tools that have already been vetted by a colleague.
With the surge in high-throughput experimentation, chemists now crave more than just basic purity benchmarks. Reliable 1H and 13C NMR, LC-MS, and even elemental analysis all contribute to confidence in batch-to-batch consistency. A spot check of vendor offerings over the past year shows most reputable outfits include a full analytical panel with shipments of 5-Bromo-2-Chloro-3-Cyanopyridine. In my time supporting method development, flagging unexpected minor impurities early saved us from headaches in downstream biological screening.
Reproducible yields during purification often tip the balance in favor of one intermediate over another. While other pyridine derivatives can sometimes trap solvent, isolating this molecule by crystallization or trituration usually proves straightforward. As a personal note, lab teams overwhelmingly prefer intermediates that won’t cling to silica columns for hours. Faster workups translate directly to more compounds screened and faster project timelines.
Sustainable chemistry threads run through more conversations by the month. Many pyridine derivatives rely on harsh reagents in older synthetic methods—think halogenation with elemental bromine or chlorination agents that raise safety concerns. Fortunately, literature reports show progress toward greener protocols, including milder halogen sources and more selective catalytic systems. Building 5-Bromo-2-Chloro-3-Cyanopyridine under conditions that avoid chlorinated solvents and dirty metal residues adds value, not only for the environment but for downstream customers tight on regulatory compliance.
I’ve participated in exploratory workshops where we weighed whether to pay extra for greener intermediates. The long-term benefits—winning regulatory approvals, cutting VOC emissions, reducing hazardous waste costs—often outweigh the short-term savings from older processes. For organizations facing scrutiny from both internal sustainability teams and external audits, the push for greener options becomes less about a marketing tagline and more about operational reality.
With each passing year, the pressure mounts for research teams to deliver novel, patent-worthy compounds under tighter timelines. Intermediates like 5-Bromo-2-Chloro-3-Cyanopyridine are at the center of these efforts, enabling faster iteration and deeper dives into new chemical space. The modularity of the molecule allows diverse analogs to emerge, supporting not just pharma but agrochemical and materials science pursuits.
From my perspective, what excites teams most is the freedom to explore both known and unknown reactivity. For example, swapping in heteroaromatic partners at the bromine site using modern coupling techniques, followed by rapid diversification at the chlorine or cyano positions. Each step unlocks new property combinations, whether the goal is to improve activity, tweak solubility, or evade metabolic degradation.
The demand for molecules ready to step into more advanced SAR campaigns remains strong. Even contract research organizations have started advertising custom syntheses based on multi-substituted pyridines, recognizing where commercial value lies. For any innovator, the right intermediate often spells the difference between a dead end and a breakthrough. Experience shows that access to such inventive chemistry lowers barriers for small teams without the means to invent every intermediate themselves.
Online forums and real-world conferences now pulse with exchanges about emerging synthetic strategies. 5-Bromo-2-Chloro-3-Cyanopyridine often gets a mention, particularly where efficiency and platform diversification take center stage. Sharing practical notes—solubility in various solvents, reactivity quirks, clean-up strategies—gives others a leg up in their own campaigns. I’ve learned more from five minutes of candid discussion with a peer than from scanning dozens of vendor catalog entries.
This collaborative attitude extends to open-source chemical databases, where successful transformations involving this molecule appear more frequently. Projects based on community feedback naturally advance faster than isolated efforts. Among colleagues, the biggest wins come from open dialogue, not secret-keeping.
Availability bottlenecks still frustrate purchasers. Building partnerships with reputable suppliers who offer robust documentation and batch history, including impurity profiles, goes a long way. Chemists should ask for analytical data up front and, where possible, validate with in-house equipment before betting a full campaign on a new shipment.
For organizations rolling out green chemistry mandates, the solution means more than changing suppliers. Encouraging development teams to pilot new methods—such as mechanochemistry or flow synthesis—reduces waste and supports scalable cleaner protocols. Such shifts require investment, both in training and in updated equipment, but the reward is a more resilient, regulatory-ready supply chain.
Knowledge management plays its part. Investing in shared electronic lab notebooks and regular cross-team reviews accelerates both awareness and adoption of valuable intermediates. Open-source initiatives and academic-industry partnerships further shorten the learning curve for teams venturing into pyridine chemistry for the first time. A wider culture of sharing, learning, and constructive critique keeps everyone moving forward.
The history of 5-Bromo-2-Chloro-3-Cyanopyridine’s rise in the chemistry toolbox says a lot about where science is heading. No single intermediate fits every challenge, but a compound that consistently powers discovery across drug and materials pipelines earns its status. At its core, value comes not from complexity, but from practical flexibility. Day by day, molecules like this let chemists chase bold ideas, sidestep old bottlenecks, and resourcefully respond to new global demands. Bench experience, literature evidence, and real-world problem solving converge here—reminding us that backbone chemistry, applied with insight and creative grit, sets the pace for modern synthetic science.